Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Tirzepatide Tirzepatide is a once-weekly injectable medication originally developed to treat type 2 diabetes
[10] [11] The medication is administered as a once-weekly subcutaneous injection, with a recommended starting dose of 2.5 mg, increased by 2.5 mg every 4 weeks until the maintenance dose (5 mg, 10 mg, or 15 mg) is reached
The process as claimed in claim 20, wherein the pH is about 3 to about 6
(Other formulations of Zepbound will not be covered.) There may be updates to the covered drugs
US$ 27.15
US$ 20.36
US$ 23.75
US$ 25.95
